
|Articles|May 1, 2004
Iris-fixated phakic IOL could offer options
Santa Ana, CA-Patients who either are severely myopic or fear laser surgery are one step closer to an alternative refractive treatment with the anticipated FDA approval of the Artisan/Verisyse phakic IOL (AMO).
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA issues Complete Response Letter to Sydnexis for SYD-101 pediatric myopia treatment
2
Nanoscope Therapeutics releases positive 3-year follow-up data from REMAIN study
3
Development of maculopathy associated with systemic medications
4
Proactive strategies and sustained delivery advance glaucoma care
5

















































.png)


